GGHC
TMDX icon

Gilder Gagnon Howe & Co’s Transmedics TMDX Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$609K Sell
6,130
-77
-1% -$10K 0.01% 231
2025
Q4 		$755K Sell
6,207
-968
-13% -$121K 0.01% 224
2025
Q3 		$805K Buy
7,175
+400
+6% +$46.8K 0.01% 226
2025
Q2 		$908K Buy
6,775
+916
+16% +$101K 0.01% 203
2025
Q1 		$394K Buy
+5,859
New +$403K 0.01% 216
2024
Q4 		– Sell
-27,602
Closed -$4.33M – 275
2024
Q3 		$4.33M Buy
+27,602
New +$4.25M 0.05% 157

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gilder Gagnon Howe & Co's TMDX Position: Q1 2026 in Review

Gilder Gagnon Howe & Co reduced its Transmedics (TMDX) stake by 1.2% in Q1 2026, selling an estimated $10K and leaving 6,130 shares worth $609K. The position accounts for 0.01% of the portfolio, ranked #231.

Gilder Gagnon Howe & Co first reported a position in TMDX in Q3 2024 and has held it in 6 quarters since. The position peaked at $4.33M in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Gilder Gagnon Howe & Co held 6,130 shares of Transmedics worth $609K as of Q1 2026.
  • Gilder Gagnon Howe & Co sold 77 Transmedics shares in Q1 2026, an estimated $10K.
  • Transmedics made up 0.01% of Gilder Gagnon Howe & Co's portfolio in Q1 2026, its #231 holding.
  • Gilder Gagnon Howe & Co first reported a position in Transmedics in Q3 2024 and has held it in 6 quarters since.
  • Gilder Gagnon Howe & Co's Transmedics position peaked at $4.33M in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2026, filed 15 May 2026.